BDMD Statistics
Total Valuation
BDMD has a market cap or net worth of $37.85 million. The enterprise value is $55.73 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BDMD has 26.84 million shares outstanding. The number of shares has increased by 0.29% in one year.
| Current Share Class | 26.84M |
| Shares Outstanding | 26.84M |
| Shares Change (YoY) | +0.29% |
| Shares Change (QoQ) | -25.73% |
| Owned by Insiders (%) | 68.16% |
| Owned by Institutions (%) | 1.71% |
| Float | 794,953 |
Valuation Ratios
The trailing PE ratio is 2.91.
| PE Ratio | 2.91 |
| Forward PE | n/a |
| PS Ratio | 0.98 |
| Forward PS | n/a |
| PB Ratio | 0.92 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 4.47 |
| EV / Sales | 1.50 |
| EV / EBITDA | 3.39 |
| EV / EBIT | 3.64 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.77 |
| Quick Ratio | 1.44 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 1.24 |
| Debt / FCF | n/a |
| Interest Coverage | 26.55 |
Financial Efficiency
Return on equity (ROE) is 33.39% and return on invested capital (ROIC) is 17.75%.
| Return on Equity (ROE) | 33.39% |
| Return on Assets (ROA) | 14.22% |
| Return on Invested Capital (ROIC) | 17.75% |
| Return on Capital Employed (ROCE) | 35.34% |
| Revenue Per Employee | $259,001 |
| Profits Per Employee | $87,086 |
| Employee Count | 143 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 3.59 |
Taxes
In the past 12 months, BDMD has paid $1.49 million in taxes.
| Income Tax | 1.49M |
| Effective Tax Rate | 10.57% |
Stock Price Statistics
The stock price has decreased by -51.00% in the last 52 weeks. The beta is -1.02, so BDMD's price volatility has been lower than the market average.
| Beta (5Y) | -1.02 |
| 52-Week Price Change | -51.00% |
| 50-Day Moving Average | 2.08 |
| 200-Day Moving Average | 4.15 |
| Relative Strength Index (RSI) | 32.60 |
| Average Volume (20 Days) | 571,985 |
Short Selling Information
The latest short interest is 276,933, so 1.03% of the outstanding shares have been sold short.
| Short Interest | 276,933 |
| Short Previous Month | 105,918 |
| Short % of Shares Out | 1.03% |
| Short % of Float | 34.84% |
| Short Ratio (days to cover) | 0.56 |
Income Statement
In the last 12 months, BDMD had revenue of $37.04 million and earned $12.45 million in profits. Earnings per share was $0.49.
| Revenue | 37.04M |
| Gross Profit | 32.65M |
| Operating Income | 15.32M |
| Pretax Income | 14.09M |
| Net Income | 12.45M |
| EBITDA | 16.45M |
| EBIT | 15.32M |
| Earnings Per Share (EPS) | $0.49 |
Full Income Statement Balance Sheet
The company has $3.27 million in cash and $20.88 million in debt, giving a net cash position of -$17.61 million or -$0.66 per share.
| Cash & Cash Equivalents | 3.27M |
| Total Debt | 20.88M |
| Net Cash | -17.61M |
| Net Cash Per Share | -$0.66 |
| Equity (Book Value) | 39.76M |
| Book Value Per Share | 1.55 |
| Working Capital | 26.79M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$6.31 million and capital expenditures -$2.85 million, giving a free cash flow of -$9.17 million.
| Operating Cash Flow | -6.31M |
| Capital Expenditures | -2.85M |
| Free Cash Flow | -9.17M |
| FCF Per Share | -$0.34 |
Full Cash Flow Statement Margins
Gross margin is 88.16%, with operating and profit margins of 41.35% and 33.62%.
| Gross Margin | 88.16% |
| Operating Margin | 41.35% |
| Pretax Margin | 38.04% |
| Profit Margin | 33.62% |
| EBITDA Margin | 44.43% |
| EBIT Margin | 41.35% |
| FCF Margin | n/a |
Dividends & Yields
BDMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.29% |
| Shareholder Yield | -0.29% |
| Earnings Yield | 32.67% |
| FCF Yield | -24.05% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BDMD has an Altman Z-Score of 3.48 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.48 |
| Piotroski F-Score | 3 |